Enteral Feeding Devices Market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Enteral Syringes, Giving Sets, and Consumables), Age Group (Adult and Pediatrics), Application (Gastrointestinal Diseases, Cancer, Malnutrition, Neurological Disorders, and Other Applications), and End User (Hospitals, Home Care, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027
The global enteral feeding devices market was valued at $2,828.52 million in 2019 and is projected to reach $4,426.54 million by 2027 at a CAGR of 5.5% from 2020 to 2027.
Enteral nutrition is a way of medically delivering nutritionally complete feed that contains protein, fat, carbohydrates, minerals, and water. This therapy involves the passage of nutrition directly into the stomach, duodenum, or jejunum. Enteral feeding devices are medical devices used to provide medications and nutrition in patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others. These devices are placed into the stomach, duodenum, or jejunum via either the nose, mouth, or through percutaneous route. Enteral nutrition can be administered via enteral pumps and enteral feeding tubes. Generally, enteral feeding devices are used in operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and in severely ill patients even at home.
Increase in prevalence of chronic disorders such as cancer and neurological disorders are the major factor that contributes toward the growth of the enteral feeding devices market. Moreover, other factors that fuel the market growth include rise in adoption of enteral nutrition, increase in geriatric population, and surge in incidences of malnutrition cases. However, stringent governmental regulations and inadvertent dislodgment of tubes leading to accidental disabilities and deaths impede the market growth. Conversely, development of new products with technological advancement and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the market growth.
The global enteral feeding devices market is segmented into product, age group, application, end user, and region. Based on product, the market is divided into enteral feeding pump, enteral feeding tube, enteral syringe, giving set, and consumable. The enteral feeding tubes segment is further classified into enterostomy feeding tube, nasoenteric feeding tube, and oroenteric feeding tube. The enterostomy feeding tube segment is further categorized into gastrostomy feeding tube, percutaneous endoscopic jejunostomy (PEJ) tube, and percutaneous radiological gastrostomy and jejunostomy tube. The gastrostomy feeding tube segment is sub-segmented into percutaneous endoscopic gastronomy feeding tube (PEG), balloon gastrostomy tube, and low-profile balloon gastrostomy (buttons).
Based on the age group, the market is bifurcated into adult and pediatrics. Based on application, the market is categorized into gastrointestinal disease, cancer, malnutrition, neurological disorder, and other applications. The cancer segment is further segmented into head & neck cancer, gastrointestinal cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. By end user, the market is divided into hospital, ambulatory surgical center (ASCs), and home care. Based on region, it is analyzed for across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS • The study provides an in-depth analysis of the global enteral feeding devices market with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
• Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
By Application • Gastrointestinal Diseases
o Head & Neck Cancers
o Gastrointestinal Cancers
o Liver Cancer
o Pancreatic Cancer
o Esophageal Cancer
• Neurological Disorders
• Other Applications
By End User • Hospitals
• Ambulatory Surgical Centers (ASCs)
• Home Care
By Region o North America
- Rest of Europe
- Rest of Asia-Pacific
• Saudi Arabia
• South Africa
• Rest of LAMEA
List of key players profiled in the report • Fresenius SE & Co. KGaA
• Boston Scientific Corporation
• Cook Medical, Inc.
• Cardinal Health Inc.
• Becton, Dickinson and Company
• Moog Inc.
• B. Braun Melsungen AG
• Owens & Minor, Inc.
• Nestlé S.A.
List of the other key players (not included in the report) includes Applied Medical Technology, Amsino International, Inc., CAIR LGL, and CONMED Corporation.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Aug 2021
Major players in the aseptic packaging market are Reynolds Group Holdings Limited, Amcor Limited, Tetra Laval International S.A, Greatview Aseptic Packaging Co. Ltd., Tetra Pak International SA, Sig Combibloc AG, SIG Combiboc Obeikan, ELOPAK Group, Sealed Air Corporation, DS Smith Plc, and UFlex Limited. The global aseptic packaging...
The global n-hexane market reached a volume of 2.8 Million Tons in 2020. Looking forward, the analyst expects the market to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries....
At present, the pharmaceutical industry is dominated by the presence of small molecule products, which represent close to 80% of the overall pipeline. Even though biologics have shown significant promise in the treatment of a wide range of disorders, in recent years, approval of novel small molecules has been...
Global Optical Genome Mapping Market, By Component (Instruments v/s Consumables), By Application (Genome Assembly, SV Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Clinical Laboratories, Others), By Region, Competition Forecast...
Free Fatty Acid Receptor 1 - Drugs In Development, 2021 Summary According to the recently published report ’Free Fatty Acid Receptor 1 - Drugs In Development, 2021’; Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 18 molecules. Out...
Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Chromatography Resins Market 2021-2025 The analyst has been monitoring the chromatography resins market and it is poised to grow by $ 1.22 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on chromatography resins market provides a holistic analysis, market size and forecast,...
As the global chemicals industry is at the onset of the recovery phase, companies are focusing on identifying and monetizing new opportunities in the industry. The majority of the chemical industries are likely to record volume growth of 4% to 8% in the short term, depending on the chemical sub-segment and product portfolio. A large volume...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.